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ABSTRACT
OBJECTIVE: The objective of this study has been to test the ability of variables of a psychological 
model to predict antiretroviral therapy medication adherence behavior.
METHODS: We have conducted a cross-sectional study among 172 persons living with HIV/AIDS 
(PLWHA), who completed four self-administered assessments: 1) the Psychological Variables 
and Adherence Behaviors Questionnaire, 2) the Stress-Related Situation Scale to assess the 
variable of Personality, 3) The Zung Depression Scale, and 4) the Duke-UNC Functional Social 
Support Questionnaire. Structural equation modeling was used to construct a model to predict 
medication adherence behaviors.
RESULTS: Out of all the participants, 141 (82%) have been considered 100% adherent to 
antiretroviral therapy. Structural equation modeling has confirmed the direct effect that 
personality (decision-making and tolerance of frustration) has on motives to behave, or act 
accordingly, which was in turn directly related to medication adherence behaviors. In addition, 
these behaviors have had a direct and significant effect on viral load, as well as an indirect effect 
on CD4 cell count. The final model demonstrates the congruence between theory and data 
(x2/df. = 1.480, goodness of fit index = 0.97, adjusted goodness of fit index = 0.94, comparative fit 
index = 0.98, root mean square error of approximation = 0.05), accounting for 55.7% of the variance.
CONCLUSIONS: The results of this study support our theoretical model as a conceptual 
framework for the prediction of medication adherence behaviors in persons living with HIV/AIDS. 
Implications for designing, implementing, and evaluating intervention programs based on the 
model are to be discussed.
DESCRIPTORS: HIV Long-Term Survivors Acquired, psychology. Medication Adherence. 
Immunodeficiency Syndrome, drug therapy. Models, Psychological. Patient Medication 
Knowledge. Health Knowledge, Attitudes, Practice.
2Adherence, ART, and Mexico Sagarduy JLY et al.
https://doi.org/10.11606/S1518-8787.2017051006926
INTRODUCTION 
In Mexico, since the beginning of the 2000s, significant effort has been made to provide 
persons living with HIV/AIDS (PLWHA) with antiretroviral medication in a free, timely 
way. Despite the evident advancements in this matter1, ironically, there has been little 
progress in the knowledge of how many PLWHA throughout the country are exhibiting 
medication adherence behaviors to antiretroviral therapy (ART)2. Except for one national 
study, which has included a representative sample of 2,054 PLWHA3, most of the studies 
have focused on samples of patients being treated in health care institutions, with an 
additional characteristic: studies are conducted without the support of a theoretical 
model that would predict how psychological or social variables influence the practice of 
medication adherence behaviors4-6. 
In the fields of psychology and health, such theoretical models are necessary because they 
help link basic and applied levels, in addition to having conceptual categories that allow 
researchers to predict whether or not a patient will practice ART adherence behaviors7,8. 
Based on this reasoning, years ago, a psychological model was proposed for the research 
of adherence behaviors in persons living with chronic diseases in general, and with 
HIV/AIDS in particular9. As shown in Figure 1, the model attempts to show the interaction 
of psychological and biological variables in four phases. Phase 1 has three psychological 
process variables: 1) personality or stress-related situations (including the behavior 
pattern of decision-making, tolerance of ambiguity, and tolerance of frustration), 2) the 
motives underlying the practice of adherence behaviors, and 3) behaviors related to past 
and current competencies. Phase 2 includes the HIV infection and other comorbidities. 
Phase 3 covers two types of behaviors: those related to therapeutics, and those related 
to the disease. Phase 4 includes conventional biological markers (CD4 lymphocytes and 
levels of viral load) and other health data. 
Personality (in stress-related situations) is a process variable in which an individual displays 
patterns of behavior that are consistent over time. These patterns may give place to stress 
reactions when persons face situations in which: (a) the consequences of practicing a 
certain behavior are unpredictable and optional – unpredictability, (b) the stimuli signals to 
which the individual has to respond are ambiguous – ambiguity, and (c) the response to a 
situation with biologically harmful consequences, or the absence of them, do not depend on 
the individual’s behavior – uncertainty. These situations would make it possible to identify a 
functional or idiosyncratic profile of behavior, based on how each individual has interacted in 
the past with situations that are functionally similar in everyday life, or ones that are related 
to different diseases and their respective treatments10,11. 
Phase one Phase two Phase three Phase four 
a) Stress-related
    situations 
b) Motives to
    behave  
c) Behavioral
    competency 
HIV infection 
and other 
comorbidities
Adherence 
behaviors
Disease-related
behaviors
Biological
function and
 health-related
results
Figure 1. Psychological model for the research of adherence behaviors by Piña & Sánchez-Sosa9.
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Motivation underlying behavior is a variable defined as an inclination or propensity to behave 
in a certain way in socially valuable circumstances. It is said that persons are motivated to 
engage in therapeutic adherence behaviors when they are willing to behave accordingly, 
after having understood the direct relationship between such behaviors and some positive 
outcome, such as an explicit expression of support, an economic reward, knowledge about a 
better understanding of their own health condition, etc12. Behavioral competencies is defined 
as the combination of knowledge, abilities, and skills acquired by an individual that allow 
him/her to respond in an effective way in situations where explicit instructions are given on 
what to do. Thus, it is said that a person is competent when he/she uses those resources to 
do what is expected, as would be the case in consuming medication as prescribed13. 
Once individuals have been diagnosed with HIV, whether or not they effectively practice 
medication adherence behaviors, or, in this case, other behaviors stemming from their 
diagnosis (traditionally defined as anxiety, depression, rage, impulsiveness, etc.), will determine 
if they are more or less likely to maintain stable biological function or obtain optimal health 
results as a part of phase four. The latter will determine the clinical progression of the disease, 
whether positive or negative, and the eventual onset of other comorbidities, belonging to 
phase two. Of these comorbidities, in Mexico, we can point out cytomegalovirus, Kaposi’s 
sarcoma, Pneumocystis jirovecii pneumonia, tuberculosis, and cerebral toxoplasmosis. Finally, 
social support has been incorporated as a variable “exogenous” to the model, consistent with 
theoretical and conceptual considerations exposed in elsewhere14,15. 
This study was conducted using the aforementioned psychological model. The objective was 
to identify which variables of the model, plus the variable of social support, would predict ART 
medication adherence behaviors in a group of PLWHA in the state of Tamaulipas, in northeast 
Mexico. According to the psychological model, Figure 2 presents a set of hypothetical relations 
between variables for the prediction of medication adherence behaviors. We expected a direct 
influence of the variable of personality on competence performance and motives, and their 
influence on medication adherence behaviors; moreover, we expected a direct influence 
of the variables of depression and social support on those behaviors; finally, we expected a 
direct influence of medication adherence behaviors on viral load and CD4 cell counts. 
METHODS 
Study Setting and Participants 
This cross-sectional study was carried out in three Outpatient Clinics for the Prevention 
and Care of HIV/AIDS (CAPASITS) in Matamoros, Tampico, and Cd. Victoria, in the state of 
Tamaulipas, Mexico. CAPASITS in Tamaulipas provides specialized care for approximately 
400 PLWHA, including patients receiving care in each center, and individuals recently 
diagnosed with HIV. Two hundred and nine patients were initially interviewed for eligibility 
purposes. The inclusion criteria to participate in this study were being: (a) aged 18 years or 
more, (b) HIV-positive or having received a confirmed AIDS diagnosis, and (c) under an ART 
treatment regimen, defined as the combination of at least two nucleoside and non-nucleoside 
inhibitors, plus one protease inhibitor. One hundred and seventy-two participants met the 
inclusion criteria, provided informed consent, and completed the assessment. In addition, 
information on biological measures (time since infection, viral load, and CD4 cell counts) 
was obtained from medical records. The study was approved by the Research and Ethics 
Committee Board of the Universidad Autónoma de Tamaulipas, as well as by the Research 
Committee Board of the Ministry of Public Health of Tamaulipas. 
Variables and Instruments 
First, we used the Psychological Variables and Adherence Behaviors Questionnaire (VPAD-24), 
designed and validated in Mexico16. It consists of 24 questions grouped into four factors. For 
this study, factor one considered the measurement of medication adherence behaviors related 
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to taking ART, and it was presented in a Likert-type format with five possible answers, ranging 
from one (“I did not take it on any day of the week”) to five (“I took it for seven days of the week”). 
The second factor, motives, included four questions in a Likert-type format with four 
possible answers, ranging from one (“It was not a determining motive”) to four (“It was a 
determining motive”). One example of a question was: “Of the following motives, how much 
did each one influence you to take your medication every day of the week?” (e.g., “I took 
it because I have experienced its benefits in my health”); the lower the score, the less 
motivation to behave. 
The performance factor of past competencies included five questions in a Likert-type format 
with five possible answers, ranging from one (never) to five (always). An example of a question 
was: “Before receiving a diagnosis of HIV seropositivity, when you had the flu, a sore throat, 
a stomach ache, etc., did you use to take medication as prescribed by your doctor?” 
Finally, the performance factor of current competencies included four questions in a 
Likert-type format with four possible answers, ranging from one (very difficult) to four 
(not difficult at all). An example of a question was: “How difficult is it for you to follow 
your doctor’s instructions regarding taking your medication?”; the lower the score, the 
lower the current competency. 
In addition, the variables of personality were measured against the Stress-Related Situations 
Scale (SVE-12), designed and validated in Mexico17. It consists of 12 questions grouped into 
three subscales: decision-making, tolerance of ambiguity, and tolerance of frustration. Each 
question was presented on a 10-point scale, in which 1 represented a situation considered 
as nonthreatening at all, and 10 as very threatening. An example of a question about 
decision-making was: “You are receiving treatment and your doctor gives you instructions 
that you must follow very carefully, but you decide to follow an alternative treatment 
(consuming homemade and holistic remedies), and you find that this seems…”. One example 
about tolerance of ambiguity was: “You have been diagnosed with a disease for which you do 
not know if there will be a cure in the short or long-term, but you must follow a treatment 
plan, and you find that this seems…”. One example about tolerance of frustration was: “You 
are receiving treatment and do everything you are told to do, but you do not receive positive 
results from healthcare personnel, and you find that this seems…”. The lower the score was, 
the lower the evaluation of stress in each situation proved to be. 
Furthermore, we used the Zung Depression Scale, previously adapted and validated in 
Mexico18. It includes 20 questions about physical and psychological symptomatology in 
the last 30 days (e.g., I notice that I am losing weight; I have trouble sleeping; I feel bored, 
discouraged, and sad; among others). Each question was designed in a Likert-type format 
with four possible answers, ranging from one (very few times) to four (most of the time). 
A lower score meant lower levels of depressive symptomatology. 
Finally, we used the Duke-UNC Functional Social Support Questionnaire, previously adapted 
and validated in Mexico19. It includes 11 questions that measure the perceived support of 
significant persons in the patient’s social environment (e.g., my family and friends come 
to visit me). The questions are in a Likert-type format of four points, ranging from one 
(less than I wish or expect) to four (more than I wish or expect). A lower score meant less 
perceived social support. 
From medical records, we obtained information about the ART regimen and the main 
biological variables at work, which included the length of the infection in months, as well 
as the levels of viral load and CD4 cell counts. Length of infection was defined as the time 
elapsed in months since the diagnosis of HIV seropositivity. Viral load was defined as the 
amount of copies of virus/ml, considering the register < 400 copies/ml as an indicator of 
virus suppression. The CD4 cell counts were defined as the amount of cells/mm3, considering 
an optimal indicator those patients who registered > 201 cells/mm3. 
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Data Analysis 
A first analysis was carried out to obtain descriptive statistics – means, standard deviations (SD), 
and minimum and maximum values of the answers – from each of the independent variables. 
Immediately afterwards, the bivariate analysis was carried out with Pearson’s correlation 
coefficient, which included the medication adherence behaviors and the variables of the model, as 
well as the variable of social support. Finally, using structural equation modeling, several trajectory 
analyses were conducted, with which we can specify the direct and indirect relationship among 
variables20. Following recommendations on the matter, different indicators of goodness of fit were 
used: Chi-square (x2), the relationship between Chi-square and degrees of freedom (x2/df, whose 
value must be ≤ 3), the goodness of fit index (GFI), the adjusted goodness of fit index (AGFI), 
the comparative fit index (CFI), and the root mean square error of approximation (RMSEA). 
Non-significant values of chi-square, above 0.90 in GFI, AGFI, CFI, as well as those under 0.80 in 
RMSEA, combined, reflected the accuracy of the data in the model21,22. 
RESULTS 
Measures and Values 
As shown in Table 1, means and SD are specified for the different assessment instruments, 
as well as the maximum and minimum possible scores, the scores obtained, and the values 
of Cronbach’s Alpha (α) for each variable, as they were grouped in their respective subscales. 
Sociodemographic, Clinical, and Behavioral Characteristics of the Participants 
The average age of the 172 PLWHA of this sample (Table 2) was 37.9 years (95%CI 36.4–39.5). 
Most of the participants were men (n = 106), unmarried (n = 96), and had less than nine 
years of formal education (n = 126). The average time they had been living with HIV was 
51.1 months (95%CI 44.9–58.4). In addition, 145 of them (84.8%) presented undetectable 
levels of viral load or ≤ 400 copies/ml, while 151 (88.3%) registered CD4 cell counts equal 
or superior to 201 cells/mm3. On the other hand, 141 (82%) participants stated they were 
100% adherent to ART, that is, they answered that they had taken the medications as they 
had been prescribed during the seven days prior to the study. 
Bivariate Analyses 
Table 3 shows the correlations between the study variables. Only one correlation between 
the medication adherence behaviors and the variable of motives to behave was found 
(r = 0.751). In addition, for the variable of personality, we can point out the correlation 
between decision-making and tolerance of ambiguity (r = 0.599), tolerance of frustration 
(r = 0.635), and social support (r = 0.184), as well as between tolerance of ambiguity and 
tolerance of frustration (r = 0.710) and depression (r = 0.162), and, in a negative sense, 
between tolerance of frustration and the variable of motives to behave (r = -0.204). 
Table 1. Descriptive statistics of the study variables and Cronbach’s alpha of 172 persons living with 
HIV/AIDS in Tamaulipas, Mexico. 
Measure Mean SD
Range Range Cronbach’s
(Possible) (Current) alpha (α)
Decision-making 13.0 10.2 3–30 3–30 0.83
Tolerance of ambiguity 16.9 9.9 3–30 3–30 0.80
Tolerance of frustration 23.9 15.3 6–60 6–60 0.82
Motives to behave 11.4 5.7 4–16 4–16 0.92
Past competencies 16.2 7.2 5–25 5–25 0.88
Current competencies 17.0 3.7 4–20 4–20 0.75
Depression 40.0 8.8 20–80 20–69 0.76
Social support 47.9 9.5 11–55 11–55 0.87
6Adherence, ART, and Mexico Sagarduy JLY et al.
https://doi.org/10.11606/S1518-8787.2017051006926
Neither the variables of past competencies nor the variables of current competencies 
showed a correlation with any of the stress-related situations or the variable of motivation 
to behave; furthermore, current competencies negatively correlated with depression 
(r = -0.640), and positively with social support (r = 0.462). Finally, depression and social 
support had negative correlation (r = -0.396). 
Structural Equation Modeling 
Considering the hypothetical relationships described in Figure 2, in the first model we 
included the variables of the theoretical model and social support. The significant parameters 
Table 2. Sociodemographic, clinical, and behavioral characteristics of 172 persons living with HIV/AIDS 
in Tamaulipas, Mexico. 
Variable n* %*
Age (years)* 37.9 (20–72) 36.4–39.5
Gender
Male 106 61.6
Female 66 38.4
Marital status
Single 96 55.8
Married or cohabitating 71 41.3
Missing data 5 2.9
Education status (years)
Illiterate 3 1.7
Less than 9 years 126 73.2
More than 9 years 42 24.4
Missing data 1 0.5
Occupation
Employed 59 34.3
Unemployed 113 65.7
Time since infection (months)* 51.5 (6–40) 44.9–58.4
Viral load (copies/ml)
Undetectable 145 84.8
Between 401–30,000 5 2.9
More than 30,000 20 11.7
Missing data 1 0.6
CD4 cell count (cell/mm3)
Less than 200 20 11.7
Between 201–400 73 42.7
More than 400 78 45.6
Medication adherence behaviors
100% adherents 141 82.0
Non-adherents 31 18.0
* For the variables of age and time since infection, the values are presented in mean (range) and 95%CI. 
Table 3. Correlation matrix of psychological variables, social support, and medication adherence 
behaviors of 172 persons living with HIV/AIDS in Tamaulipas, Mexico.
Variable 2 3 4 5 6 7 8 9
1. Adherence behaviors 0.170 -0.042 -0.113 0.751b 0.045 0.135 0.019 0.023
2. Decision-making 0.599b 0.635b 0.008 -0.002 -0.099 0.138 0.184a
3. Tolerance of ambiguity 0.710b -0.146 0.061 -0.097 0.162a 0.128
4. Tolerance of frustration -0.204b -0.014 -0.109 0.133 0.078
5. Motives -0.096 0.009 -0.051 0.011
6. Past competencies -0.017 0.058 -0.007
7. Current competencies -0.640b 0.462b
8. Depression -0.396b
9. Social support
a p < 0.05
b p < 0.01
7Adherence, ART, and Mexico Sagarduy JLY et al.
https://doi.org/10.11606/S1518-8787.2017051006926
in this model were the direct effect of decision-making (β = 0.233; p = 0.018) and tolerance 
of frustration on the variable of motives to behave (β = -0.285; p = 0.009). In addition, high 
motivation was directly related to medication adherence behaviors (β = 0.745; p = 0.001), 
which were also related to lower levels of viral load (β = -0.319; p = 0.001), which, in turn, 
showed a direct effect on CD4 cell counts (β = -0.302; p = 0.018). However, the results of the 
remaining parameters were not significant, and the indicators of goodness of fit were not 
optimal (GFI = 0.84; AGFI = 0.75; CFI = 0.72; RMSEA = 0.13). For this reason, we proceeded 
to look for a model with better fit, setting the different parameters that were not significant 
in the prior modeling to zero. 
As shown in Figure 3, the second analysis resulted in a model with better fit. We found 
that two stress-related situations, decision-making (β = 0.202; p = 0.033) and tolerance of 
frustration (β = -0.344; p = 0.001), had a direct effect on motives to behave, explaining the 7.2% 
variance between them. The variable of motives to behave had a direct and significant effect 
on medication adherence behaviors (β = 0.746; p = 0.001), mediating the influence of the two 
stress-related situations, decision-making (β = 0.150; p < 0.05) and tolerance of frustration 
(β = -0.257; p < 0.05), which together, explain a 55.7% variance. In addition, medication 
adherence behaviors, in turn, showed a direct and significant effect on lower levels of viral 
load (β = -0.317; p = 0.001), which directly affected CD4 cell counts (β = -0.302; p = 0.001), 
explaining the 9.1% variance between them. For the estimation of the model, we used the 
method of maximum likelihood. The data were adjusted for the multivariate normality and 
we used scores corresponding to the totals obtained in the different scales and subscales. 
The statistics of goodness of fit for the final model were optimal in every case: x2/df. = 1.480; 
GFI = 0.97; AGFI = 0.94; CFI = 0.98; RMSEA = 0.05. 
Depression
 Medication
adherence
behaviors  
Viral load
 CD4 cell
counts 
 
Decision-
making
 
Tolerance of
ambiguity 
 
Tolerance of
frustration 
 
Past behavioral
competencies 
 
Motives to
behave
 
Social
support
 
Current 
behavioral
competencies 
 
Figure 2. Hypothetical model of the relationships between variables and adherence behavior.
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Goodness of fit: (x2/df. = 1.480; GFI = 0.97, AGFI = 0.94, CFI = 0.98; RMSEA = 0.05). 
Solid lines indicate significant relationships (p < 0.05).
Figure 3. Path analyses of medication adherence behavior among 172 persons living with HIV/AIDS 
in Tamaulipas, Mexico.
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DISCUSSION 
The goal of this study was to test the influence of variables of a psychological model and 
the role of social support on medication adherence behaviors related to ART in a sample of 
172 PLWHA in the state of Tamaulipas, Mexico. One hundred and forty participants reported 
being 100% adherent, that is, they had consumed all medications as prescribed during the 
week prior to the study. Structural equation modeling revealed the direct influence of two 
stress-related situations on the motives underlying the practice of medication adherence 
behavior. The results partially coincide with those reported among PLWHA in the state of 
Sonora, in northwest Mexico23, even though they are slightly different, since in this sample 
there is no evidence of direct influence of the variable of motives to behave on behavioral 
competencies, or the latter on medication adherence behaviors. 
Personality (stress-related situations) is defined as a consistent way of behaving in circumstances 
in which the consequences of a response cannot be predicted (decision-making), or in which 
the consequences of a certain behavior do not depend on the actions of the PLWHA (tolerance 
of frustration). In this situation, we are addressing the most deeply rooted variable in a person’s 
life, which is crucial for the prediction of medication adherence behaviors. Decision-making 
related to therapy can sometimes compete with the practice of adherence behavior24,25, 
because when PLWHA face situations that involve two or more simultaneous options (taking 
the medication or not, or more specifically, following orders to further take them or not), such 
conditions can provoke stressful reactions with variable length. In this sample, we found that, 
in general, participants showed low levels of stress related to decision-making, judging by the 
mean response values for this variable (13.0 points on a scale ranging from 3 to 30 points). 
Along the same lines, there are also those who face situations in which a specific activity is 
carried out (taking the medications as prescribed by healthcare personnel), but the result 
(in the form of reinforcing stimuli) is less than expected, is delayed, is not granted, is taken away 
without reason, etc. The result is thus the manifestation of behavioral patterns that exhibit low 
tolerance of frustration26,27. Both of these stress-related situations also had a direct influence 
on the motives underlying medication adherence behaviors. 
It is important to remember that the variable of motives to behave is related to the most 
current, cumulative11, and changing background of each individual patient. In this item, 
the questions concerning the reasons for practicing medication adherence behaviors were 
related to intrinsic stimulus (having knowledge about an optimal health condition and 
experiencing it), and extrinsic stimulus (receiving verbal manifestations of recognition or 
positive results, such as rewards from healthcare personnel or other significant persons in 
the patient’s social environment). 
As exposed in Table 1, the participants have an optimal level of competences, as they know 
about their health condition, but at the same time they know what do with that information, 
to identify which positive results are associated with the practice of medication adherence 
behaviors. Knowing the causes or the characteristics of the disease and treatment seems to have 
an influence on how certain actions are performed, which, in this case, would include taking the 
ART according to instructions given by the healthcare team. Nevertheless, it is worth mentioning 
that past and current competencies did not have a significant impact on the practice of medication 
adherence behaviors, particularly if we consider two facts in relation to other studies, based in 
our theoretical model. These facts determined a solid relationship between motives to behave 
and behavioral competencies, especially when we worked with samples of individuals who were 
100% adherent or who had high percentages of adherence28,29, such as is the case of our study; 
in this study, 141 (82%) of the participants reported being 100% adherent to ART. 
On the other hand, despite having found low levels of depression and high scores of perceived 
social support, contrary to what has been reported in previous studies30-33, neither variable 
played a significant role in any of the structural models analyzed. This is a particularly 
intriguing result, as the first score was 16.2 and 17.0 for past and current competencies (of a 
possible maximum of 25 and 20, respectively), which would reflect an optimal competence 
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performance in both moments. Meanwhile, the second score was 40 (of a possible range of 
20 to 80), which we could say is equivalent to a “moderate” level of depression. Regarding 
social support, the mean score was high – it reached 47.5 (of a possible range of 11 to 55) –, 
meaning that the participants in this sample perceived exceptional social support rom 
information and trust. One possible explanation would perhaps be the fact that the study 
was carried out with a sample of PLWHA who were mostly 100% adherent, that is, with 
persons who have proved to be competent and have significant sources of social support. 
In this study, we worked with a sample of PLWHA that had been living with the disease for an 
average of 51.5 months, in this way it is possible to argue that, as more time with the infection 
passes, and if the individual is not transitioning towards AIDS, the psychological or social 
variables will have a greater or smaller impact, just as it has been reported in several studies 
which included PLWHA from different regions of Mexico34-36. This means that, if PLWHA have, 
at this time, already undergone treatment programs, and at the same time have been exposed 
to intervention programs carried out at health institutions, it is reasonable to believe that 
they are more likely to be psychologically and socially accustomed to the disease and to ART, 
which is seen as a necessary requirement for subsequent medication adherence behaviors37,38. 
Finally, an issue that cannot be overlooked and that reveals the influence of the two stress-related 
situations on stress and motivation is that, (a) knowing how to face such situations, and (b) doing 
things based on a specific motivation are both critical elements in the prediction of adherence 
behaviors. In addition, as described in the results section, these elements also have subsequent 
influence on lower levels of viral load and high CD4 cell counts. This finding is consistent with 
information reported in studies carried out by other authors39,40. In summary, it is understandable 
that, in this sample, optimal adherence resulted in low levels of viral load and high CD4 cell counts. 
We must keep in mind that 84.8% of the PLWHA presented low levels of viral load (undetectable 
or < 400 copies/ml), and 88.3% obtained high CD4 cell counts (> 201 cells/mm3). 
Even with the results obtained in this study, it is important to recognize some limitations. The first 
limitation includes the size of the sample, which consisted of approximately 40% of PLWHA 
exposed to treatment regimens with antiretroviral medication in the five CAPASITS centers in the 
state of Tamaulipas, in northeast Mexico. The second one, because this is a sample in which most 
of the PLWHA reported being 100% adherent to antiretroviral therapy (n = 141; 82%), we have 
to consider a likely overestimation in the self-reporting of the practice of adherence behaviors. 
Finally, the lack of influence of the variables of behavior competencies, depression, and social 
support is also worth noting. In previous studies with high or 100% adherence samples, one 
of the key variables has been the variable of behavioral competence. However, as mentioned, 
at least in this sample, no influence was found, since two of the variables related to personality 
(decision-making and tolerance of frustration) played a role of first order28,29. 
For such reasons, and according to previous discussion on this topic, further studies need to be 
carried out using a broader sample of PLWHA from different regions of the country. Our current 
theoretical model will undergo strict empirical tests in future research, comparing PLWHA who 
(a) are adherent or have adherence problems, (b) have demonstrated the pertinent behavioral 
competencies or not, and (c) show particular symptoms of depression or have established social 
support networks. This last aspect is especially important because the results would allow us to 
design, implement, and evaluate specific intervention programs based on the concrete needs 
of patients in the respective institutions where they are routinely treated.
CONCLUSIONS
This transversal study revealed the influence of two stress-related situations (decision-making 
and tolerance of frustration) on the underlying motives of ART medication adherence behaviors 
in a sample of 172 PLWHA in the state of Tamaulipas, Mexico. These situations also had an 
influence on decreased levels of viral load and high CD4 cell counts. Variance, in combination 
with the variables of the theoretical model on which the study was based, reached 55.7%. 
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Something worth mentioning is the lack of influence of the variables of depression, social 
support, and motives to behave on behavioral competencies. In this context, the results 
contribute to empirically validate our theoretical model and to explore theoretical intervention 
options in order to increase the practice of medication adherence behaviors in patients.
Therefore, this would also mean trying to establish guidelines that would guarantee the 
relationship between the conceptual categories of the model and the procedures and 
techniques from a behavioral perspective.
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